相似文献
1
The Fate of Fusions.
Cells. 2018 Dec 29;8(1):13. doi: 10.3390/cells8010013.
2
Tumor-Cell-Macrophage Fusion Cells as Liquid Biomarkers and Tumor Enhancers in Cancer.
Int J Mol Sci. 2020 Mar 9;21(5):1872. doi: 10.3390/ijms21051872.
3
Macrophage-tumor cell fusions from peripheral blood of melanoma patients.
PLoS One. 2015 Aug 12;10(8):e0134320. doi: 10.1371/journal.pone.0134320. eCollection 2015.
4
Leukocyte-cancer cell fusion: initiator of the warburg effect in malignancy?
Adv Exp Med Biol. 2011;714:151-72. doi: 10.1007/978-94-007-0782-5_8.
5
Cancer. Fusion for moving.
Science. 2013 Nov 8;342(6159):699-700. doi: 10.1126/science.1244270.
6
Distant Relations: Macrophage Functions in the Metastatic Niche.
Trends Cancer. 2018 Jun;4(6):445-459. doi: 10.1016/j.trecan.2018.03.011. Epub 2018 May 3.
7
Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival.
Sci Adv. 2018 Sep 12;4(9):eaat7828. doi: 10.1126/sciadv.aat7828. eCollection 2018 Sep.
8
Fusion between Intestinal epithelial cells and macrophages in a cancer context results in nuclear reprogramming.
Cancer Res. 2011 Feb 15;71(4):1497-505. doi: 10.1158/0008-5472.CAN-10-3223. Epub 2011 Feb 8.
9
CTC clusters in cancer progression and metastasis.
Med Oncol. 2017 Jan;34(1):12. doi: 10.1007/s12032-016-0875-0. Epub 2016 Dec 23.
10
Relevance of circulating hybrid cells as a non-invasive biomarker for myriad solid tumors.
Sci Rep. 2021 Jul 1;11(1):13630. doi: 10.1038/s41598-021-93053-7.
引用本文的文献
1
Fusion Cell Markers in Circulating Tumor Cells from Patients with High-Grade Ovarian Serous Carcinoma.
Int J Mol Sci. 2022 Nov 24;23(23):14687. doi: 10.3390/ijms232314687.
2
Identification and Morphological Characterization of Features of Circulating Cancer-Associated Macrophage-like Cells (CAMLs) in Endometrial Cancers.
Cancers (Basel). 2022 Sep 21;14(19):4577. doi: 10.3390/cancers14194577.
3
Cell fusion in cancer hallmarks: Current research status and future indications.
Oncol Lett. 2021 Jul;22(1):530. doi: 10.3892/ol.2021.12791. Epub 2021 May 16.
4
Altered Tumor Plasticity after Different Cancer Cell Fusions with MSC.
Int J Mol Sci. 2020 Nov 6;21(21):8347. doi: 10.3390/ijms21218347.
5
Tumor stem cells fuse with monocytes to form highly invasive tumor-hybrid cells.
Oncoimmunology. 2020 Jun 16;9(1):1773204. doi: 10.1080/2162402X.2020.1773204.
6
Tumor-Cell-Macrophage Fusion Cells as Liquid Biomarkers and Tumor Enhancers in Cancer.
Int J Mol Sci. 2020 Mar 9;21(5):1872. doi: 10.3390/ijms21051872.
7
Intratumor Heterogeneity and Therapy Resistance: Contributions of Dormancy, Apoptosis Reversal (Anastasis) and Cell Fusion to Disease Recurrence.
Int J Mol Sci. 2020 Feb 15;21(4):1308. doi: 10.3390/ijms21041308.
8
In Vivo Cell Fusion between Mesenchymal Stroma/Stem-Like Cells and Breast Cancer Cells.
Cancers (Basel). 2019 Feb 5;11(2):185. doi: 10.3390/cancers11020185.
本文引用的文献
1
Gene Regulatory Network Modeling of Macrophage Differentiation Corroborates the Continuum Hypothesis of Polarization States.
Front Physiol. 2018 Nov 27;9:1659. doi: 10.3389/fphys.2018.01659. eCollection 2018.
2
The epithelial-to-mesenchymal transition induced by tumor-associated macrophages confers chemoresistance in peritoneally disseminated pancreatic cancer.
J Exp Clin Cancer Res. 2018 Dec 11;37(1):307. doi: 10.1186/s13046-018-0981-2.
3
Circulating Tumor Cells are an Independent Predictor of Shorter Survival in Patients Undergoing Resection for Pancreatic and Periampullary Adenocarcinoma.
Ann Surg. 2020 Mar;271(3):549-558. doi: 10.1097/SLA.0000000000003035.
4
Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival.
Sci Adv. 2018 Sep 12;4(9):eaat7828. doi: 10.1126/sciadv.aat7828. eCollection 2018 Sep.
5
Pancreatic cancer circulating tumor cells: applications for personalized oncology.
Expert Rev Mol Diagn. 2018 Sep;18(9):809-820. doi: 10.1080/14737159.2018.1511429. Epub 2018 Aug 22.
6
Circulating and disseminated tumor cells in pancreatic cancer and their role in patient prognosis: a systematic review and meta-analysis.
Oncotarget. 2017 Aug 4;8(63):107223-107236. doi: 10.18632/oncotarget.19928. eCollection 2017 Dec 5.
7
"Stealth dissemination" of macrophage-tumor cell fusions cultured from blood of patients with pancreatic ductal adenocarcinoma.
PLoS One. 2017 Sep 28;12(9):e0184451. doi: 10.1371/journal.pone.0184451. eCollection 2017.
8
Neither epithelial nor mesenchymal circulating tumor cells isolated from breast cancer patients are tumorigenic in NOD- mice.
NPJ Breast Cancer. 2016 Mar 9;2:16004. doi: 10.1038/npjbcancer.2016.4. eCollection 2016.
9
Clinical impact of circulating tumor cells and therapy response in pancreatic cancer.
Eur J Surg Oncol. 2017 Jun;43(6):1050-1055. doi: 10.1016/j.ejso.2017.01.241. Epub 2017 Feb 12.
10
A Melanoma Lymph Node Metastasis with a Donor-Patient Hybrid Genome following Bone Marrow Transplantation: A Second Case of Leucocyte-Tumor Cell Hybridization in Cancer Metastasis.
PLoS One. 2017 Feb 1;12(2):e0168581. doi: 10.1371/journal.pone.0168581. eCollection 2017.
Zotero 插件